Neonatal Hypoglycemia after Initiation of Late Preterm Antenatal Corticosteroids at a Single Center
ACOG ePoster. Uquillas K. Apr 27, 2018; 211542
Kristen Uquillas
Kristen Uquillas
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)
Introduction: After the publication of the Antenatal Late Preterm Steroids (ALPS) trial in 2016, LAC+USC Medical Center began to offer antenatal corticosteroids to patients at risk of late preterm birth. The ALPS trial found an association between late preterm corticosteroids and neonatal hypoglycemia, however this was not fully described.

Methods: We retrospectively examined data from all neonates born in the late preterm period between 2/1/15–7/31/17. Patients were excluded according to the ALPS study criteria. Hypoglycemia was defined as glucose
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings